April 20, 2024 04:01 (IST)
Strides Pharma receives USFDA approval for Triamcinolone Acetonide Ointment USP, 0.05%
Bengaluru/IBNS: Strides Pharma Science Limited (Strides) announced that its step-down wholly owned subsidiary, Strides Pharma Global Pte. Limited, Singapore, has received approval for Triamcinolone Acetonide Ointment USP, 0.05% from the United States Food & Drug Administration (USFDA).
Latest Headlines